Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022.

ABSTRACT:

Importance

There is increasing recognition from regulatory agencies that racial and ethnic representation in clinical trials is inadequate and linked to health inequities. The extent of racial inequities in clinical trial participation is unclear because prior studies have synthesized enrollment data from published trials, which often do not report participant race and ethnicity.

Objective

To evaluate racial and ethnic inequities in oncology clinical trial participation in a contemporary cohort of patients with cancer before and during the COVID-19 pandemic.

Design, setting, and participants

This cohort study used a nationwide electronic health record-derived deidentified database, which includes data for approximately 280 US cancer clinics (approximately 800 sites of

SUBMITTER: Pittell H 

PROVIDER: S-EPMC10362465 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature